Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252538 · ClinicalTrials.gov registry record
Genetic and Biochemical Markers of Interferon-Induced Depression.
A clinical trial of Depression, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 133
- Enrollment target
- 3
- Study locations
NCT00252538 is a study of Depression that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 133 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00252538, a study of Depression, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to identify predictors and associated biochemical markers of interferon-induced depression. It is hypothesized that genetic variation in genes related to the serotonergic system may predict vulnerability to interferon-induced depression.
Conditions Studied
Study Locations (3)
California
- VA Medical Center, Long Beach - Long Beach
Minnesota
- VA Medical Center, Minneapolis - Minneapolis
Oregon
- VA Medical Center, Portland - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252538
The ClinicalTrials.gov registry entry for NCT00252538 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00252538 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Minnesota, Oregon.
Frequently Asked Questions
What is clinical trial NCT00252538 about?
NCT00252538 is a clinical study titled "Genetic and Biochemical Markers of Interferon-Induced Depression.". The purpose of this study is to identify predictors and associated biochemical markers of interferon-induced depression. It is hypothesized that genetic variation in genes related to the serotonergic system may predict vulnerability to interferon-induced depression.
What is the current status of trial NCT00252538?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2006-04. Estimated completion is 2009-09.
What conditions does trial NCT00252538 study?
This clinical trial studies the following conditions: Depression.
Who is sponsoring clinical trial NCT00252538?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252538 being conducted?
This trial has 3 study locations across California, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.